Antidepressants Linked To Stroke Risk

A study published in Neurology revealed that individuals who use common antidepressants called selective serotonin reuptake inhibitors (SSRIs) could have a heightened risk of suffering a stroke.

A team of investigators looked at past studies to analyze the connection between antidepressant use and stroke. Evidence from 16 studies was pooled, with over 500,000 total participants included. Overall antidepressant users were about 40 to 50 percent more likely to suffer bleeding in or around the brain.

Researchers focused on the popular antidepressants including; Celexa (citalopram), Lexapro (escitalopram), Paxil (paroxetine), Prozac (fluoxetine), Viibryd (vilazodone), and Zoloft (sertraline).

“Overall, these results should not deter anyone from taking an SSRI when it is needed,” explained the study’s author Daniel G. Hackam, a researcher at Western University in London, Ontario in a prepared statement. “In general these drugs are safe, and obviously there are risks to having depression go untreated. But doctors might consider other types of antidepressants for people who already have risk factors for these types of strokes, such as those taking blood thinners, people who have had similar strokes already or those with severe alcohol abuse.”

The researchers noted that approximately 24.6 of the strokes happen among every 100,000 people annually. Use of antidepressants heightens the risk to one extra stroke for every 10,000 people in a year.

One of the limitations noted of the study was that it didn’t factor in the possibility that patients who use SSRIs are “sicker” that individuals who did not take the medications. These factors include habits like smoking and drinking. The study also didn’t take into account chronic disease like diabetes that may plague patients who take SSRIs.

“We can’t infer cause and effect from this,” said Hackam on how the findings of the study do not show direct correlation between antidepressants and bleeding in the brain.

Reuters reported that biological factors could be at play. SSRIs can make it difficult for the platelets, otherwise known as blood cells, to clump and create clots. As a result, there may be a decline in the activity of a person’s platelets.

Even with the results of the study, the researchers believe the medications are still safe

“I think that overall, these medications are quite safe,” Hackam told Reuters Health.

An editorial, compiled by Emer McGratgh and Martin O’Donnell, accompanied the published study in the journal and emphasized the study as “best current evidence of an association between SSRI use and risk of ICH.” They also advised that the uptick in ICH should not stop medical professionals from prescribing SSRIs.

“These findings emphasize the importance of appropriate patient selection and avoidance of inappropriate prescribing, which assumes particular importance in patients at increased risk of ICH,” wrote the authors in the editorial. “SSRIs may be associated with an increased risk of ICH but the absolute risk in populations is low. These findings add to the totality of evidence for efficacy and safety of antidepressants overall and within drug classes, used to inform evidence-based prescribing.”

Antidepressant usage has been linked with a number of adverse side effects, including but not limited to, stomach bleeding, high blood pressure, birth defects, and even autism.

You May Also Like


  • This field is for validation purposes and should be left unchanged.

, , , , ,

No comments yet.

Leave a Reply

  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Merck’s Falsification of Vaccine Data Exposed

Merk’s dirty little secret has been exposed. A pair of lawsuits, one filed by former employees of Merck and the other by doctors, alleged the company knew its mumps vaccine was less effective than the supposed 95 percent efficiency level. According to court documents the former virologists employed by Merck filed a whistleblower lawsuit four […]

Testosterone Therapy Linked To Heart-Attack, Stroke and Death

Millions of men have turned to testosterone therapy to treat symptoms of aging. However, they may not be aware that they are putting themselves at risk for heart attack or stroke. According to the latest study published in the journal PLOS ONE, researchers report that within 90 days of taking the hormone the risk of […]

What Is Doribax?

According to the FDA the antibacterial drug Doribax, that has been used to treat patients who develop pneumonia on ventilators, carries an increased risk of death and has a lower clinical cure rate by injection compared a similar drug known as Primaxin. What is Doribax? Doribax is an antibiotic that fights serious infections caused by […]

Is Using Tylenol or Ibuprofen During Pregnancy linked to ADHD?

What is a mother to do if she becomes ill during pregnancy?  The risks of consuming common drugs when pregnant are complex.  Although many doctors assure mothers that taking Tylenol is safe, a recent study by JAMA Pediatrics suggests otherwise.  The study found that mothers who used Tylenol for fever reduction while pregnant reported greater […]

Paxil Linked To Breast Cancer

City of Hope Cancer researchers indicate that a new test called the AroER Tri-Screen, desgined to look for drug side effects that could cause cancer, found a potential link between Paxil and breast cancer.  Paxil is a widely prescribed anti depressant. Research Researchers have found that Paxil has a weak estrogen effect that could increase […]

Latest Medical Device Injury News

Report Raises Concerns Over Heart Defibrillator Leads

The Food and Drug Administration (FDA) has just announced that they received a report that a St. Jude Durata cardiac defibrillator lead conductor became externalized; meaning the wire carrying electricity from the heart defibrillator to the heart was exposed through its insulation, a potentially dangerous and life-threatening defect.

HeartSine Class 1 Defibrillator Recall

HeartSine sent out a letter to customers in September, warning that the defibrillators may intermittently turn on and off, eventually depleting the battery.

FDA Medical Device Approval Based On Little Evidence

More than half of the high-risk cardiovascular devices approved in the past decade had no supporting active control data.

St. Jude Medical Gets FDA Warning

St. Jude Medical Inc. said it received a FDA warning about manufacturing and quality-control problems at its Sylmar, California, plant.

Hospira Still Facing Manufacturing And Regulatory Issues

Hospira has sent out 11 device notifications so far in 2013, including recall and device corrections. The company also said it sent notices to customers about some of its infusion pumps that had to either be recalled, fixed or adjusted.